AstraZeneca drops Rigel rheumatoid arthritis pill

By Ben Hirschler LONDON (Reuters) – AstraZeneca has decided to end development of fostamatinib, a rheumatoid arthritis pill that was one of its few late-stage experimental medicines, following disappointing overall results. The decision is a blow to AstraZeneca’s already sparse new-drug pipeline and a bigger setback for Rigel Pharmaceuticals, the U.S. biotech firm that struck a licensing deal for the medicine with Britain’s second-biggest drugmaker in 2010. …

Ohio teacher awarded $171,000 after firing over artificial insemination

By Bob Driehaus CINCINNATI, Ohio (Reuters) – A Catholic school teacher fired by the Cincinnati Archdiocese after becoming pregnant by artificial insemination was awarded $171,000 in damages on Monday by a federal court jury that ruled her dismissal violated U.S. anti-discrimination laws. The U.S. District Court jury in Cincinnati awarded Christa Dias $71,000 in lost wages and emotional distress damages and ordered the archdiocese to pay her $100,000 in punitive damages. …

1 89 90 91 92 93 101